Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS‐650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 9, 2015-09 ,pp. : 2813-2823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of the Resistance of Hepatitis C Virus NS5B Polymerase Inhibitors via Docking and Molecular Dynamics Simulation

By  

MOLECULAR INFORMATICS, Vol. 34, Iss. 2‐3, 2015-02 ,pp. : 78-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

First Report on Exploring Structural Requirements of 1,2,3,4- Tetrahydroacridin-9(10H)-one Analogs as Antimalarials Using Multiple QSAR Approaches: Descriptor-Based QSAR, CoMFA-CoMSIA 3DQSAR, HQSAR and G-QSAR Approaches

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 16, Iss. 1, 2013-01 ,pp. : 7-21

Bentham Science Publishers

Access to resources Recommend Favorite

P2‐Quinazolinones and Bis‐Macrocycles as New Templates for Next‐Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK‐2748 and MK‐6325

By  

CHEMMEDCHEM, Vol. 10, Iss. 4, 2015-04 ,pp. : 727-735

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reinvestigation of the reaction of [Ru₃(CO)₁₂] with 2-mercaptobenzothiazole: X-ray structure of [(μ-H)₂Ru₃ (μ-η²-C₇H₄NS₂)(μ₃-η²-C₇H₄NS₂)(CO)₇]

By Hanif Khandakar M.   Islam Mohammad S.   Kabir Shariff E.   Malik K. M. Abdul   Miah Md. Arzu   Wakelin Nathan  

Journal of Chemical Crystallography, Vol. 33, Iss. 11, 2003-11 ,pp. : 859-865

Springer Publishing Company

Access to resources Recommend Favorite